Castle Biosciences Inc (CSTL)
29.81
+0.93
(+3.22%)
USD |
NASDAQ |
Nov 22, 16:00
29.81
0.00 (0.00%)
After-Hours: 20:00
Castle Biosciences Enterprise Value: 565.13M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 565.13M |
| November 21, 2024 | 539.08M |
| November 20, 2024 | 527.04M |
| November 19, 2024 | 538.80M |
| November 18, 2024 | 511.63M |
| November 15, 2024 | 517.24M |
| November 14, 2024 | 593.70M |
| November 13, 2024 | 620.86M |
| November 12, 2024 | 648.31M |
| November 11, 2024 | 676.32M |
| November 08, 2024 | 662.59M |
| November 07, 2024 | 663.15M |
| November 06, 2024 | 644.95M |
| November 05, 2024 | 602.66M |
| November 04, 2024 | 672.40M |
| November 01, 2024 | 658.67M |
| October 31, 2024 | 701.24M |
| October 30, 2024 | 697.60M |
| October 29, 2024 | 676.32M |
| October 28, 2024 | 637.67M |
| October 25, 2024 | 607.83M |
| October 24, 2024 | 619.86M |
| October 23, 2024 | 623.22M |
| October 22, 2024 | 632.73M |
| October 21, 2024 | 621.82M |
| Date | Value |
|---|---|
| October 18, 2024 | 643.36M |
| October 17, 2024 | 655.11M |
| October 16, 2024 | 674.97M |
| October 15, 2024 | 666.86M |
| October 14, 2024 | 688.68M |
| October 11, 2024 | 606.15M |
| October 10, 2024 | 521.95M |
| October 09, 2024 | 534.53M |
| October 08, 2024 | 569.78M |
| October 07, 2024 | 556.08M |
| October 04, 2024 | 551.32M |
| October 03, 2024 | 525.30M |
| October 02, 2024 | 526.70M |
| October 01, 2024 | 516.07M |
| September 30, 2024 | 528.10M |
| September 27, 2024 | 523.07M |
| September 26, 2024 | 526.95M |
| September 25, 2024 | 543.59M |
| September 24, 2024 | 561.62M |
| September 23, 2024 | 581.59M |
| September 20, 2024 | 623.20M |
| September 19, 2024 | 597.12M |
| September 18, 2024 | 592.41M |
| September 17, 2024 | 617.10M |
| September 16, 2024 | 608.77M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
79.17M
Minimum
Jun 05 2023
2.005B
Maximum
Feb 09 2021
622.49M
Average
459.92M
Median
Jan 17 2023
Enterprise Value Benchmarks
| Delcath Systems Inc | 300.07M |
| Star Equity Holdings Inc | 33.44M |
| Exact Sciences Corp | 11.34B |
| CytoSorbents Corp | 58.43M |
| Progyny Inc | 1.079B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 2.269M |
| Revenue (Quarterly) | 85.78M |
| Total Expenses (Quarterly) | 80.70M |
| EPS Diluted (Quarterly) | 0.08 |
| Gross Profit Margin (Quarterly) | 81.80% |
| Profit Margin (Quarterly) | 2.65% |
| Earnings Yield | 0.70% |
| Normalized Earnings Yield | 0.7045 |